With respect to targeting GBM metabolism to improve clinical outcomes, GBM cell lines have shown increased radiosensitivity when LDHA is or other glycolytic pathways are inhibited in vitro.37, 38, 39, 40. Here, LDHA is linked to glioblastoma.